Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$62.8K
7.56K shares
What this filing means
DE VERNEUIL VANINA plans to sell 7.56K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $62.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001438
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
7.56K
Shares to sell
$62.8K
Approx. market value
3.12K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
3.12KTotal acquired3.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 3.12K | — |
| Total | 3.12K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.45K
Market value
$33.1K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.12K
Market value
$29.7K
2/24/2026
Total
Units
7.56K
Value
$62.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/23/2026 | 4.45K | $33.1K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 3.12K | $29.7K | NASDAQ | Planned |
| Total | 7.56K | $62.8K | ||